HPV

Although HPV vaccination in adolescence can successfully prevent six kinds of cancer, rates in Tennessee remain relatively low, while occurrence of these cancers remains relatively high compared to the rest of the country.  Pamela Hull, assistant professor of medicine, and her colleagues are conducting a study funded by the HPV ACTIVE TIPs award, in collaboration with the Cumberland Pediatric Foundation, to test a model for disseminating a web-based quality improvement coaching program to pediatric clinics. Read More

Vanderbilt is at the epicenter of a human papillomavirus (HPV)-associated cancer epidemic, according to Ronald Alvarez, MD, chair of the Department of Obstetrics and Gynecology at Vanderbilt. Read More

The association between tobacco use and cancer is well known. But there are other risk factors for cancer that are less recognized, including the link between cancer and certain viruses. Read More

Tennessee has one of the lowest human papillomavirus (HPV) vaccination rates in the nation, and investigators at Vanderbilt University Medical Center (VUMC) are hoping to change this by improving the way medical providers present these vaccines to patients and by improving patient and patient family education. Read More

Douglas Lowy, M.D., acting director of the National Cancer Institute (NCI), warned that worldwide death rates from cervical cancer are expected to increase in low- and middle-income countries during the next 15 years unless steps are taken to prevent the cancer from occurring. Almost all cases of cervical cancer are linked to a viral infection. Read More

Nearly 39,000 new cancers associated with the human papillomavirus (HPV) will be diagnosed in the United States this year. Although HPV vaccines can prevent the majority of these cancers, vaccination rates remain low across the country. Read More

In response to low national vaccination rates for the human papillomavirus (HPV), Vanderbilt-Ingram Cancer Center (VICC) has joined 68 of the nation’s other NCI-designated cancer centers in recommending increased HPV vaccination for the prevention of cancer. Read More

A new study suggests that lowering the dose of radiation therapy for some head and neck cancer patients may improve outcomes and cause fewer long-term side effects. Read More

(Vanderbilt University) A sore throat can be a symptom of allergies or a cold virus but if the sore throat persists it may be an early symptom of head and neck cancer. Vanderbilt will hold a free head and neck cancer screening day, Friday, May 3, 9 a.m. –… Read More

Vaccinating young males and females against several types of human papillomavirus (HPV) could dramatically reduce the incidence of HPV-related cancers worldwide, according to Douglas Lowy, M.D., deputy director of the National Cancer Institute. Read More

Vanderbilt University’s Vikrant Sahasrabuddhe, M.D., MPH, DrPH, received the IAS/ANRS Young Investigator Award at the International AIDS Conference last week in Washington, D.C. Read More

Measuring levels of an enzyme in head and neck tumors may indicate how the tumor will respond to radiation therapy. Read More

An inexpensive, low-tech test for cervical cancer may be a good option for screening for the disease among HIV-infected women in developing countries. Read More

Host cell protein may be a target for strategies to limit spread of virus-induced squamous cell cancers. Read More